TrialHypertension research : official journal of the Japanese Society of Hypertension2017

Long-term (52-week) safety and efficacy of Sacubitril/valsartan in Asian patients with hypertension.

Ouppatham Supasyndh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.